European Pharmaceutical Review

AUGUST 24, 2022

ANTIBODY-DRUG conjugates (ADCs) are therapeutic molecules designed as highly targeted medicines with the promise of changing the way we treat cancer and other diseases. Finally, existing platform conjugation chemistries are often restricted in their space of design and are, for instance, limited to a DAR of 2 or 4.

Compounding 82

Compounding Pharmaceutical Companies Pharmaceutical Companies 82

PharmaShots

MARCH 9, 2023

Education: She is a Post Graduate Research Fellow in Gastroenterology and Immunology from Stanford University School of Medicine. She developed various mobile technologies and pioneered early electronic labels including NFC tags, which helped Thin Film Electronics win the Wall Street Innovation Award and the Global Technology Award.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

European Pharmaceutical Review

NOVEMBER 10, 2022

A new wave of medicines has emerged in recent years to supplement the well-established small and large molecule platforms that have historically dominated the market. Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). What constitutes a complex medicine?

Labelling 96

Labelling Compounding 96

The Physician Pharmacist

SEPTEMBER 14, 2023

Hosted by licensed pharmacist and now 4th-year medical student Nathan Gartland, this podcast explores the unique pathway of combining pharmacy and medicine. In episode 2, Dr. Bryce Brohol joins Nathan to discuss his experience as a second-year medical student at Liberty University College of Osteopathic Medicine.

Medical Schools 52

Medical Schools Hospitals Communication Patient Care 52